STOCK TITAN

VIAVI SOLUTIONS (VIAV) SEC Filings, May 6-20, 2026

VIAV NASDAQ

Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.

VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.

Rhea-AI Summary

Viavi Solutions is offering 11,111,111 shares of common stock pursuant to this prospectus supplement. The offering price is $45.00 per share for total gross proceeds of $499,999,995, with underwriters’ discounts of $1.35 per share. We estimate net proceeds to us of approximately $484.4 million, which we currently intend to use to repay the $450 million aggregate principal amount of our Term Loan B. The underwriters have an option to purchase up to 1,666,666 additional shares within 30 days.

Shares outstanding were 233,907,870 as of April 25, 2026; the prospectus shows common stock to be outstanding immediately after this offering of 245,018,981 shares (or 246,685,647 shares if the underwriters’ option is exercised in full). The prospectus supplement also presents March 28, 2026 cash and capitalization as adjusted to reflect the offering and application of net proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
prospectus
-
Rhea-AI Summary

Viavi Solutions Inc. is offering common stock with an aggregate public offering price of $500,000,000. This prospectus supplement is preliminary and subject to completion, dated May 19, 2026. The underwriters have a 30-day option to purchase additional shares with an aggregate public offering price of up to $75,000,000. The company states estimated net proceeds will be used to repay the $450 million aggregate principal amount of its 7-year Term Loan B entered into in October 2025; any excess will be used for working capital and general corporate purposes. Shares outstanding were 233,907,870 as of April 25, 2026. The offering assumes no exercise of the underwriters' option unless noted.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.39%
Tags
prospectus
-
Rhea-AI Summary

Viavi Solutions Inc. reported board-level governance changes focused on committee leadership and composition. Effective May 12, 2026, independent director Joanne Solomon was appointed Chair of the Audit Committee, replacing Donald Colvin, who remains an independent director and Audit Committee member.

The Board states Mr. Colvin’s decision to step down as chair was not due to any disagreement regarding the company’s operations, policies, or practices, and that the move supports board refreshment and succession planning. Ms. Solomon has served on the Board and Audit Committee since February 2022 and is designated an “audit committee financial expert.”

On the same date, the Board appointed independent director Doug Gilstrap to the Corporate Development Committee. Mr. Gilstrap, who joined the Board in November 2022, also serves on the Compensation Committee. These changes adjust committee responsibilities while maintaining overall board continuity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
current report
Rhea-AI Summary

Viavi Solutions Inc. ownership disclosure: Capital World Investors files Amendment No. 1 to report beneficial ownership of 11,570,319 shares, representing 5.0% of 231,389,345 shares stated as outstanding. The filing shows sole voting and sole dispositive power over those shares. The filing is dated 03/31/2026 with a signature dated 05/13/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
ownership
-
Rhea-AI Summary

VIAVI Solutions Inc. officer and director Oleg Khaykin reported a proposed sale of 136,547 common shares, with an aggregate market value of $7,076,084.02 and an approximate sale date of May 8, 2026. The notice also lists prior sales by Oleg Khaykin and the Oleg Khaykin Irrevocable Trust and Helen Khaykin Irrevocable Trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.26%
Tags
other
-
Rhea-AI Summary

VIAVI SOLUTIONS INC. President & CEO Oleg Khaykin reported selling a total of 259,880 shares of Common Stock in open-market transactions. He sold 123,333 shares on May 7, 2026 at a price of $51.43 per share and 136,547 shares on May 8, 2026 at $51.82 per share.

Following these sales, Khaykin directly holds 1,188,798 shares of Viavi common stock. The filing notes that each day’s transaction was executed in multiple trades, with prices on May 7 ranging from $51.22 to $51.68 and on May 8 from $51.75 to $52.15, with reported prices reflecting weighted averages.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
insider
Rhea-AI Summary

VIAVI Solutions Inc. lists Oleg Khaykin as an officer and director and names Oleg Khaykin Irrevocable Trust as the account for a proposed sale of 123,333 common shares, with an aggregate market value of $6,342,855.86. The approximate sale date is May 7, 2026. The securities schedule lists performance shares acquired in 2020 and restricted stock acquired in 2018 and 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
other
-
Rhea-AI Summary

VIAVI SOLUTIONS INC. President & CEO Oleg Khaykin reported an open-market sale of 34,024 shares of common stock. The shares were sold on May 6, 2026 at a weighted average price of $54.07 per share, based on multiple trades between $54.00 and $54.12. After this transaction, Khaykin directly holds 1,448,678 shares of VIAVI common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.68%
Tags
insider
-
Rhea-AI Summary

VIAVI Solutions Inc. (VIAV) is the issuer in a notice that the Oleg Khaykin Irrevocable Trust proposes to sell 34,024 common shares, with an aggregate market value of $1,837,517.16 and an approximate sale date of May 6, 2026. The notice identifies Oleg Khaykin as an officer and director and names Morgan Stanley Smith Barney LLC as broker. It also lists May 5, 2026 sales of 104,552 shares by Oleg Khaykin and 20,238 shares by the Helen Khaykin Irrevocable Trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.68%
Tags
other
Rhea-AI Summary

VIAVI Solutions Inc. officer Luke Scrivanich reported a proposed sale of 10,693 common shares, with an aggregate market value of $566,729.00 and an approximate sale date of May 6, 2026. Morgan Stanley Smith Barney LLC is named as broker. Scrivanich also reported selling 13,901 common shares on February 13, 2026, for gross proceeds of $369,628.98.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.68%
Tags
other

FAQ

How many VIAVI SOLUTIONS (VIAV) SEC filings are available on StockTitan?

StockTitan tracks 196 SEC filings for VIAVI SOLUTIONS (VIAV), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for VIAVI SOLUTIONS (VIAV)?

The most recent SEC filing for VIAVI SOLUTIONS (VIAV) was filed on November 13, 2026.